High Tower Advisors, LLC Allogene Therapeutics, Inc. Transaction History

High Tower Advisors, LLC

  • $68.3 Billion
  • Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 29,650 shares of ALLO stock, worth $65,526. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,650
Previous 30,556 2.97%
Holding current value
$65,526
Previous $71,000 16.9%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$2.08 - $3.5 $1,884 - $3,171
-906 Reduced 2.97%
29,650 $83,000
Q1 2024

May 06, 2024
BUY
$2.92 - $5.63 $14,600 - $28,150
5,000 Added 19.56%
30,556 $136,000
Q4 2023

Feb 12, 2024
SELL
$2.28 - $3.5 $69,090 - $106,060
-30,303 Reduced 54.25%
25,556 $82,000
Q3 2023

Nov 08, 2023
SELL
$3.17 - $5.96 $1,483 - $2,789
-468 Reduced 0.83%
55,859 $177,000
Q2 2023

Aug 14, 2023
SELL
$4.53 - $6.74 $2,409 - $3,585
-532 Reduced 0.94%
56,327 $279,000
Q1 2023

May 11, 2023
SELL
$4.92 - $8.21 $2,400 - $4,006
-488 Reduced 0.85%
56,859 $280,000
Q4 2022

Feb 08, 2023
SELL
$5.62 - $11.11 $60,201 - $119,010
-10,712 Reduced 15.74%
57,347 $360,000
Q2 2022

Aug 10, 2022
BUY
$6.78 - $12.28 $118,650 - $214,900
17,500 Added 34.61%
68,059 $776,000
Q1 2022

May 12, 2022
SELL
$7.65 - $15.29 $229 - $458
-30 Reduced 0.06%
50,559 $462,000
Q4 2021

Feb 10, 2022
SELL
$13.13 - $24.52 $16,018 - $29,914
-1,220 Reduced 2.35%
50,589 $753,000
Q3 2021

Nov 12, 2021
BUY
$21.01 - $27.64 $115,555 - $152,020
5,500 Added 11.88%
51,809 $1.33 Million
Q2 2021

Aug 06, 2021
SELL
$23.49 - $35.8 $46,980 - $71,600
-2,000 Reduced 4.14%
46,309 $1.21 Million
Q4 2020

Feb 10, 2021
BUY
$25.24 - $43.45 $97,174 - $167,282
3,850 Added 8.66%
48,309 $1.22 Million
Q3 2020

Nov 13, 2020
SELL
$32.38 - $44.96 $59,125 - $82,096
-1,826 Reduced 3.95%
44,459 $1.68 Million
Q2 2020

Aug 10, 2020
SELL
$18.39 - $54.04 $186,842 - $549,046
-10,160 Reduced 18.0%
46,285 $1.98 Million
Q1 2020

May 21, 2020
BUY
$18.22 - $28.25 $1.03 Million - $1.59 Million
56,445 New
56,445 $1.1 Million
Q4 2019

Feb 14, 2020
SELL
$24.82 - $31.4 $574,334 - $726,596
-23,140 Closed
0 $0
Q3 2019

Nov 12, 2019
BUY
$26.11 - $32.99 $306,479 - $387,236
11,738 Added 102.95%
23,140 $630,000
Q2 2019

Aug 13, 2019
BUY
$25.56 - $31.09 $291,435 - $354,488
11,402 New
11,402 $306,000

Others Institutions Holding ALLO

# of Institutions
162
Shares Held
134M
Call Options Held
59.4K
Put Options Held
113K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $318M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email